Blue Sprig Pediatrics

Blue Sprig Pediatrics

Blue Sprig Pediatrics was established as a pediatric healthcare services company focused exclusively on center-based and in-home applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder. The firm grew through an aggressive acquisition strategy, folding dozens of independent ABA clinics into a single operational platform. While the founding principals and current leadership remain publicly unprofiled, the company's scale and national footprint are consistent with institutional private equity sponsorship. The firm deploys capital exclusively into autism care delivery, targeting clinic acquisitions, de novo center openings, and clinician recruitment across suburban and urban markets. Asset-class exposure is concentrated in healthcare services real estate — via long-term clinic leases — and operating-company equity. Blue Sprig's model combines organic patient volume growth with margin improvement through centralized billing, scheduling, and compliance infrastructure. Its geographic reach spans Texas, the Southeast, the Midwest, and the West Coast, with confirmed operational density in Houston and other major metropolitan areas. The company's rollout pace suggests deployment in the hundreds of millions of dollars, typical of healthcare roll-ups backed by growth or buyout funds. No disclosed AUM or deployment figure exists in public record. Blue Sprig does not operate a philanthropic foundation publicly, nor does it appear to maintain adjacent investment vehicles. No dated operational event from the last 24 months could be confirmed. Blue Sprig's structural differentiator lies in its pure-play focus on outcomes-based ABA therapy within a private equity roll-up architecture — a combination that separates it from both hospital-system outpatient programs and smaller independent practices. Its scale gives it negotiating leverage with payors and a centralized data infrastructure uncommon in fragmented pediatric behavioral health, positioning it as a market consolidator rather than a service innovator.